Leverage Shares 3x Long Moderna ETP (LON:MRN3)

Assets	2.28M
Expense Ratio	3.78%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+1,388.44%

Volume	1,167
Open	105.40
Previous Close	102.70
Day's Range	102.20 - 107.20
52-Week Low	3.11
52-Week High	122.00
Beta	5.89
Holdings	2
Inception Date	Dec 14, 2021

About MRN3

The Leveraged Shares 3x Long Moderna Mutual Fund is a unique financial instrument designed to amplify the returns of its underlying asset, Moderna Inc.'s stock, by a factor of three. The primary function of this fund is to provide investors with an opportunity to benefit from a threefold increase in the daily percentage change of Moderna's stock price, making it an appealing option for those seeking heightened exposure to the biopharmaceutical company's performance. This leveraged mutual fund is particularly relevant in the biotech and healthcare sectors, where Moderna is a major player due to its groundbreaking work in mRNA technology and vaccine development, including the COVID-19 vaccine. However, it is important to note that the amplified returns also come with proportional increases in risk, as losses are also tripled, making it more suitable for investors with a higher risk tolerance. In the financial market, the fund offers a significant vehicle for participating in the dynamic changes and innovations within the biotech industry, providing specialized exposure tailored to aggressive investment strategies.

• Asset Class: Equity
• Category: Health Care
• Region: North America
• Stock Exchange: London Stock Exchange
• Ticker Symbol: MRN3
• Provider: Leverage Shares
• Index Tracked: iSTOXX Leveraged 3x MRNA Index - Benchmark TR Net

Performance

MRN3 had a total return of 1,388.44% in the past year, including dividends. Since the fund's inception, the average annual return has been 79.39%.

Top Holdings

Name	Symbol	Weight
Moderna, Inc.	MRNA	300.15%
Cash	n/a	-200.15%

Data Sources: Twelve Data, Financial Modeling Prep, and more

Historical data is provided by Twelve Data. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error